Weight loss
- Analysis
- Medicine
Ultra-cheap Ozempic is coming. That’s a mixed blessing for Australians
Generic versions of the drug can cost as little as $20 a month overseas, in a glimpse of the future for Australia.
- Nick Bonyhady
Latest
Ozempic-style drug in pill form wins key approval
Australian tech health providers say they are keen to offer an oral pill version of the class of medications, which previously required injections.
- Elias Visontay, Leah Douglas and Christy Santhosh
Allira was a fierce ‘body positivity’ advocate. Then the movement soured
Former body positivity influencers are fleeing the movement, while “skinny culture” is making an alarming comeback.
- Nell Geraets
‘Backfired’: Ozempic maker’s disastrous trial and its $US475 billion meltdown
Analysts say Novo Nordisk’s new obesity drug may be obsolete before it hits the shelves, underlining a massive fall from grace for the company behind the weight loss boom.
- Colin Kruger
The five things doctors wish you’d do instead of intermittent fasting
A new major review of research found no evidence to support the method as any better for weight loss than other diets.
- Courtney Thompson
- Opinion
- Opinion
‘Ozempic neck’ is the latest ‘side effect’ of GLP-1s. It’s a symptom of something uglier
Such “conditions” are not medical issues. They’re a way for cosmetic surgeons to sell you something.
- Hannah Vanderheide
‘Watch this space’: How weight-loss drugs are triggering new eating disorders
Inappropriate prescribing and poor support are triggering anorexia in previously healthy patients taking weight-loss medications.
- Henrietta Cook
The companies that could be surprise beneficiaries of the Ozempic boom
A US investment bank is already eyeing the fuel-cost benefits for airlines of lighter passengers.
- Chris Zappone
- Opinion
- Sunday Life
Already broken your New Year’s resolution? Take this advice
It’s time to stop trying to stick to a bunch of silly, self-imposed rules.
- Wendy Squires
What science says about how weight-loss drugs affect cancer risk
A growing body of science is aiming to answer whether GLP-1 drugs can help with one of the world’s leading causes of death: cancer.
- Allyson Chiu